Nanocarriers for microRNA delivery in cancer medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanocarriers for microRNA delivery in cancer medicine

Published:2017-05 Issue:3 Volume:35 Page:350-360
ISSN:0734-9750
Container-title:Biotechnology Advances
language:en
Short-container-title:Biotechnology Advances

Author:

Fernandez-Piñeiro I.,Badiola I.,Sanchez A.

Funder

Ministry of Economy and Competitiveness

Xunta de Galicia

Ministry of Education

Publisher

Elsevier BV

Subject

Biotechnology,Bioengineering,Applied Microbiology and Biotechnology

Reference86 articles.

1. Nanoparticle-delivered antisense microRNA-21 enhances the effects of temozolomide on glioblastoma cells;Ananta;Mol. Pharm.,2015

2. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma;Babar;Proc. Natl. Acad. Sci. U. S. A.,2012

3. Developing therapeutic microRNAs for cancer;Bader;Gene Ther.,2011

4. Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells;Bertucci;Small,2015

5. First microRNA mimic enters clinic;Bouchie;Nat. Biotechnol.,2013

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells;AAPS PharmSciTech;2024-09-12

2. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

3. Delivery of miRNAs Using Porous Silicon Nanoparticles Incorporated into 3D Hydrogels Enhances MSC Osteogenesis by Modulation of Fatty Acid Signaling and Silicon Degradation;Advanced Healthcare Materials;2024-05-03

4. Near-infrared light activated and hybridization chain reaction cascaded CRISPR/Cas12a system under the enhancement of Mn2+ for intracellular biosensing;Sensors and Actuators B: Chemical;2024-01

5. MicroRNA-based nanomedicine for the treatment of head and neck cancer;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3